Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present three ...
Business Insider21h
Exact Sciences to present abstracts on multi-cancer early detection test
Exact Sciences (EXAS) will present three abstracts highlighting ... Liquid Biopsy from November 13-16, 2024, in San Diego, Calif. A new study demonstrates the ability of a multi-biomarker class MCED ...